Loading...
XSHE002772
Market cap381mUSD
Jan 08, Last price  
7.11CNY
1D
-0.84%
1Q
6.44%
Jan 2017
-65.44%
IPO
-29.17%
Name

Tianshui Zhongxing Bio-technology Co Ltd

Chart & Performance

D1W1MN
XSHE:002772 chart
P/E
17.52
P/S
1.45
EPS
0.41
Div Yield, %
7.54%
Shrs. gr., 5y
1.06%
Rev. gr., 5y
15.82%
Revenues
1.93b
-1.99%
131,314,967190,401,694263,940,603383,497,278479,520,220585,018,459739,792,782926,432,0561,155,832,4601,483,178,4911,556,146,7251,970,274,4121,931,077,659
Net income
160m
+0.78%
43,576,05763,991,71454,750,39490,880,528114,381,357158,510,283142,273,052111,939,0250106,839,7940158,351,860159,581,340
CFO
525m
+6.24%
094,555,57593,028,601170,310,081209,431,109233,392,235207,336,130231,792,554359,149,932389,318,7970493,702,411524,502,689
Dividend
May 16, 20240.3 CNY/sh
Earnings
Apr 16, 2025

Profile

Tianshui Zhongxing Bio-technology Co.,Ltd. engages in the research and development, production, and sale of edible fungi in China. It offers mushrooms under the Xi Huang, Nüwa, and Zhongxing and other brands. The company was formerly known as Tianshui Zhongxing Bio-technology Ltd. and changed its name to Tianshui Zhongxing Bio-technology Co.,Ltd. in March 2012. Tianshui Zhongxing Bio-technology Co.,Ltd. was founded in 2005 and is headquartered in Tianshui, China.
URL
http://www.tszxjy.cn/
IPO date
Jun 26, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,931,078
-1.99%
1,970,274
26.61%
Cost of revenue
1,682,667
1,666,047
Unusual Expense (Income)
NOPBT
248,410
304,228
NOPBT Margin
12.86%
15.44%
Operating Taxes
3,263
Tax Rate
1.31%
NOPAT
245,148
304,228
Net income
159,581
0.78%
158,352
 
Dividends
(210,793)
(39,289)
Dividend yield
6.79%
1.20%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,009,669
980,371
Long-term debt
1,075,006
1,622,773
Deferred revenue
118,513
Other long-term liabilities
102,905
(1,622,214)
Net debt
637,432
907,458
Cash flow
Cash from operating activities
524,503
493,702
CAPEX
(106,997)
Cash from investing activities
(56,965)
Cash from financing activities
(755,196)
FCF
368,453
180,514
Balance
Cash
1,323,518
1,695,686
Long term investments
123,725
Excess cash
1,350,689
1,597,172
Stockholders' equity
1,355,478
1,368,048
Invested Capital
4,272,155
3,114,802
ROIC
6.64%
7.59%
ROCE
4.42%
4.98%
EV
Common stock shares outstanding
393,241
392,921
Price
7.89
-5.17%
8.32
-0.48%
Market cap
3,102,674
-5.09%
3,269,101
0.92%
EV
3,743,150
4,179,628
EBITDA
517,129
579,631
EV/EBITDA
7.24
7.21
Interest
83,608
90,488
Interest/NOPBT
33.66%
29.74%